QC = Quality Cannabis
When it comes to quality control, do cannabis growers and suppliers need to take a leaf out of the pharma industry’s book?
Andrew James |
In many regions, cannabis is now considered by the public as a medicine, perhaps not so different from aspirin or ibuprofen. However, when you judge medical cannabis by the standards of the pharmaceutical industry, it’s easy to see that it falls short in terms of rigorous safety and potency testing. The grand challenge for global cannabis producers and processors is to ensure the same standard of reliable, safe and consistent products as pharmaceutical (and indeed food and beverage) manufacturers.
Despite many countries and states having passed regulations that allow medicinal and/or recreational cannabis use, regulation across regions for content, composition, adulterants, potency or levels of toxic residues are lacking standardization. Strong regulations are being introduced in some regions (California, for example, see tas.txp.to/tcs4/pesticides), but the responsibility for testing generally lies at the feet of a small number of approved independent testing laboratories.
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.